priaxon.com
Logo

Profile

Priaxon is an emerging drug discovery company with unique and proprietary drug discovery platform - PriaXplore.

PriaXplore is a toolbox consisting of several chemoinformatics methods and concepts especially designed for the application in the field of identifying new potential inhibitors of protein protein interactions (PPI). In combination with a strong and innovative synthetic chemistry PriaXplore represents the heart of a proprietary and efficient drug discovery engine.

Priaxon can exhibit a successful track record in this field which is highlighted by the partnering of the mdm2/p53 inhibitor program with Boehringer Ingelheim. 

Priaxon has a strong network of inhouse and external competence in oncology applications.

A further area of interest is the development of tailored inhibitors against bacterial virulence factors

Priaxon's approach to generate value is characterized by a unique drug discovery engine using a prorietary combination of chemoinformatic tools with innovative synthetic chemistries.

Applying the drug discovery engine Priaxon discovers and advances promising compounds to create a robust and sustainable pipeline of high impact small molecules.

  • Focus on well validated but still thrilling targets for unmet medicinal needs
  • Partnering of the discovered compounds at an early stage with global pharmaceutical companies having the capacity and expertise to develop the programs straight towards their clinical trials
  • Extraordinary interest in the future field of the discovery and development of small molecule inhibitors for protein protein interactions, especially in oncology
  • Priaxon works on own risk on targets coming from a partner to hit success criteria, which have to be mutually agreed. This business model shall lead into a license agreement between both parties in the case of success.












.